Growth Failure in STAT3 Gain-of-Function Syndrome Persists After Hematopoietic Stem Cell Transplantation
- PMID: 38787482
- DOI: 10.1007/s10875-024-01727-4
Growth Failure in STAT3 Gain-of-Function Syndrome Persists After Hematopoietic Stem Cell Transplantation
References
-
- Leiding JW, Vogel TP, Santarlas VGJ, et al. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023;151:1081–95. https://doi.org/10.1016/j.jaci.2022.09.002
-
- Gutiérrez M. Activating mutations of STAT3: Impact on human growth. Mol Cell Endocrinol. 2020;518:110979. https://doi.org/10.1016/j.mce.2020.110979
-
- Todaro F, Tamassia N, Pinelli M, et al. Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression. Haematologica. 2019;104:322–5. https://doi.org/10.3324/haematol.2018.202374
-
- Ciullini Mannurita S, Goda R, Schiavo E, et al. Case report: signal transducer and activator of transcription 3 gain-of-function and spectrin deficiency: a life-threatening case of severe hemolytic anemia. Front Immunol. 2021;11:1–6. https://doi.org/10.3389/fimmu.2020.620046
-
- Sediva H, Dusatkova P, Kanderova V, et al. Short stature in a boy with multiple early-onset autoimmune conditions due to a STAT3 activating mutation: could intracellular growth hormone signalling be compromised? Horm Res Paediatr. 2017;88:160–6. https://doi.org/10.1159/000456544
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous